Advocacy


MSHO continuously contacts legislators, provides comments to policy makers and collaborates with payers on issues of concern to those delivering care to cancer patients.

more information

Education


It is important that our members are aware of meetings, web casts, and other educational opportunities specifically designed to address the complexities of cancer care.

more information

Research


MSHO is committed to furthering the advancement of cancer care by supporting the many organizations that provide cancer clinical trials to Michigan’s cancer patients.

more information

MSHO Foundation


The MSHO Foundation is a 501c3 organization which was formed in 2011 to address the growing educational needs of hematology and oncology professionals in Michigan.

more information

Careers


MSHO offers our members an opportunity to advertise current job openings on our website. Click here to view job openings or to post a job.

more information

Welcome

The Michigan Society of Hematology and Oncology (MSHO) is a non-profit 501c(6) corporation, formed in 1985 to address the growing needs of oncologists, radiation oncologists and hematologists in all practice settings in the state.

It is the Mission of MSHO to promote exemplary care for patients with cancer and/or blood disorders through advocacy, education and research.

Upcoming Events view all events

 July 2020 
SMTWTFS
   1234
56789
1011
121314
15
161718
19202122
232425
2627
2829
30
31 
Thu
6
2020
August 6, 2020
12:00-1:00PM

Oncology Pharmacist Lunch & Lecture Series

New Drug Updates: IV Therapies

WEBINAR

view event details
Wed
19
2020
August 19, 2020
5:15-7:30PM

Hematology and Oncology Board Review and Re-Certification Evening Lecture Series

Breast Cancer & Hereditary Cancers 

WEBINAR

view event details
Thu
20
2020
August 20, 2020
12:00-1:00PM

Oncology Pharmacist Lunch & Lecture Series

New Drug Updates: Oral Oncolytics

WEBINAR

view event details

Latest News view all news

Implementation of a Single Preferred Drug List (PDL)
07/03/2020

Implementation of a Single Preferred Drug List (PDL)

Implementation of this policy is contingent upon approval of a State Plan Amendment (SPA) by the Centers for Medicare & Medicaid Services

CMS hosts varied recurring stakeholder engagement sessions to share information related to the agency’s response to COVID-19
06/30/2020

CMS hosts varied recurring stakeholder engagement sessions to share information related to the agency’s response to COVID-19

Sessions are open to healthcare community members & are intended to provide updates, share best practices, & offer attendees an opportunity to ask questions of CMS & other subject matter experts

Changes to Billing of Telehealth Services
06/29/2020

Changes to Billing of Telehealth Services

MSHO Telehealth Coverage Updates

Follow Us on Twitter

Corporate Sponsors view all sponsors